Effectiveness and safety of sofosbuvir-based direct-acting antiviral combinations in HCV-2 and HCV-3 kidney transplant recipients

Kidney Int. 2019 Apr;95(4):993-995. doi: 10.1016/j.kint.2018.11.037.

¹ CRC "A.M. and A. Migliavacca" Center for Liver Disease, Gastroenterology and Hepatology Department, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy. Electronic address: [email protected].
² Gastroenterology and Hepatology Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
³ CRC "A.M. and A. Migliavacca" Center for Liver Disease, Gastroenterology and Hepatology Department, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
⁴ Hepatology Department, Groupe Hopitalier Cochin Saint-Vincent De Paul, Paris Descartes University, Inserm U1223, Institut Pasteur, Paris, France.
⁵ Infectious Disease Department, Spedali Civili Brescia, Brescia, Italy.
⁶ Gastroenterology Department, ASST Papa Giovanni XXIII, Bergamo, Italy.
⁷ Nephrology and Kidney Transplant Department, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

No abstract available

Publication types